|
GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
|
GB937725A
(en)
|
1960-05-11 |
1963-09-25 |
Ciba Ltd |
Pyrazolo[3:4-d]pyrimidines
|
|
JPS5256693Y2
(https=)
|
1973-05-14 |
1977-12-21 |
|
|
|
IT1153216B
(it)
|
1981-10-16 |
1987-01-14 |
Schering Ag |
Procedimento per la preparazione di composti cianoeterociclici
|
|
DE3406533A1
(de)
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
|
US5310731A
(en)
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
JPS61109797A
(ja)
|
1984-11-01 |
1986-05-28 |
Yuki Gosei Yakuhin Kogyo Kk |
標識化ヌクレオチドおよび標識化ポリヌクレオチド
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
WO1990003370A1
(en)
|
1988-09-28 |
1990-04-05 |
Microprobe Corporation |
DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE
|
|
US5428125A
(en)
|
1989-07-17 |
1995-06-27 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
|
US5442039A
(en)
|
1989-07-17 |
1995-08-15 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
|
US5763596A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
|
US5795977A
(en)
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
|
US5763597A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
Orally active adenosine kinase inhibitors
|
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
|
GB9009542D0
(en)
|
1990-04-27 |
1990-06-20 |
Beecham Group Plc |
Novel compounds
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
|
US5563257A
(en)
|
1990-08-20 |
1996-10-08 |
Boehringer Mannheim Gmbh |
Phospholipid derivatives of nucleosides
|
|
DE4026265A1
(de)
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
|
US5561134A
(en)
|
1990-09-25 |
1996-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
|
US5652366A
(en)
|
1990-09-25 |
1997-07-29 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
|
|
SG80526A1
(en)
|
1990-09-25 |
2001-05-22 |
Rhone Poulenc Rorer Int |
Compounds having antihypertensive and anti- ischemic properies
|
|
ATE141502T1
(de)
|
1991-01-15 |
1996-09-15 |
Alcon Lab Inc |
Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
|
|
GB9103839D0
(en)
|
1991-02-23 |
1991-04-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
|
MX9300141A
(es)
|
1992-01-13 |
1994-07-29 |
Smithkline Beecham Corp |
Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
|
|
DE4204032A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
|
|
DE4204031A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue lipidphosphonsaeure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel
|
|
WO1993018035A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
JP2737518B2
(ja)
|
1992-03-16 |
1998-04-08 |
富士通株式会社 |
赤外線検知器の冷却構造
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
GB9208135D0
(en)
|
1992-04-13 |
1992-05-27 |
Ludwig Inst Cancer Res |
Polypeptides having kinase activity,their preparation and use
|
|
JPH07506252A
(ja)
|
1992-04-24 |
1995-07-13 |
エス・アール・アイ・インターナシヨナル |
真核細胞内でのイン・ビボ相同配列ターゲッティング
|
|
DE69328440T3
(de)
|
1992-06-19 |
2009-05-07 |
Honeywell, Inc., Minneapolis |
Infrarot kamera mit thermoelektrischer temperaturstabilisierung
|
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
TW370529B
(en)
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
|
EP0684953A4
(en)
|
1993-02-03 |
1999-12-22 |
Gensia Inc |
ADENOSINE KINASE INHIBITORS COMPRISING LYXOFURANOSYL DERIVATIVES.
|
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
|
US5679683A
(en)
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US6632789B1
(en)
|
1994-04-29 |
2003-10-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for modulating T cell responses by manipulating intracellular signal transduction
|
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
JP4145955B2
(ja)
|
1994-09-29 |
2008-09-03 |
ノバルティス アクチェンゲゼルシャフト |
ピロロ〔２，３−ｄ〕ピリミジン及びその使用
|
|
US6323201B1
(en)
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
|
US6312894B1
(en)
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
|
ES2150113T3
(es)
|
1995-04-03 |
2000-11-16 |
Novartis Ag |
Derivados de pirazol y procedimientos para la preparacion de los mismos.
|
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
|
JPH08295667A
(ja)
|
1995-04-27 |
1996-11-12 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法および剤
|
|
WO1996037777A1
(en)
|
1995-05-23 |
1996-11-28 |
Nelson Randall W |
Mass spectrometric immunoassay
|
|
US5593997A
(en)
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
WO1996040258A2
(en)
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
|
|
WO1996040256A1
(en)
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone
|
|
DK0831910T3
(da)
|
1995-06-07 |
2002-05-21 |
Searle & Co |
Kombinationsterapi med epoxy-steroid aldosteronantagonist og angiotensin II-receptorantagonist til behandling af kongestivt hjertesvigt
|
|
US5665721A
(en)
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
|
CA2245835A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
|
US5763885A
(en)
|
1995-12-19 |
1998-06-09 |
Loral Infrared & Imaging Systems, Inc. |
Method and apparatus for thermal gradient stabilization of microbolometer focal plane arrays
|
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
|
JPH09143163A
(ja)
|
1995-11-29 |
1997-06-03 |
Fuji Photo Film Co Ltd |
含窒素ヘテロ芳香族アミド類の製造方法
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
CH690773A5
(de)
|
1996-02-01 |
2001-01-15 |
Novartis Ag |
Pyrrolo(2,3-d)pyrimide und ihre Verwendung.
|
|
DE19603576A1
(de)
|
1996-02-01 |
1997-08-07 |
Bayer Ag |
Acylierte 4-Amino und 4-Hydrazinopyrimidine
|
|
GB2310952B
(en)
|
1996-03-05 |
1998-08-19 |
Mitsubishi Electric Corp |
Infrared detector
|
|
GB9611460D0
(en)
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
|
HUP9904567A3
(en)
|
1996-06-20 |
2001-10-29 |
Univ Texas |
Use of azo, thioalkyl, thiocarbonyl derivatives substituted by fused heterocycles and/or phenyl group for the preparation of pharmaceutical compositions stimulating bone growth
|
|
US5922753A
(en)
|
1996-10-23 |
1999-07-13 |
Zymogenetics, Inc. |
Methods for treating bone deficit conditions with benzothiazole
|
|
US5948776A
(en)
|
1996-10-23 |
1999-09-07 |
Zymogenetic, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5994358A
(en)
|
1996-10-23 |
1999-11-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US6153631A
(en)
|
1996-10-23 |
2000-11-28 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US6251901B1
(en)
|
1996-10-23 |
2001-06-26 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US6342514B1
(en)
|
1996-10-23 |
2002-01-29 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5919808A
(en)
|
1996-10-23 |
1999-07-06 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5990169A
(en)
|
1996-10-23 |
1999-11-23 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
EP0942925B1
(en)
|
1996-12-06 |
2006-11-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1 beta converting enzyme
|
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JPH10206995A
(ja)
|
1997-01-21 |
1998-08-07 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
AU755062B2
(en)
|
1997-02-07 |
2002-12-05 |
Princeton University |
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
DK0970084T3
(da)
|
1997-03-19 |
2003-09-29 |
Abbott Gmbh & Co Kg |
Pyrrolo[2,3-d]pyrimidiner og deres anvendelse som inhibitorer for tyrosinkinase
|
|
AU7449598A
(en)
|
1997-05-23 |
1998-12-11 |
Nippon Shinyaku Co. Ltd. |
Medicinal composition for prevention or treatment of hepatopathy
|
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
|
ATE404539T1
(de)
|
1997-10-02 |
2008-08-15 |
Eisai R&D Man Co Ltd |
Kondensierte pyridinderivate
|
|
US6649631B1
(en)
|
1997-10-23 |
2003-11-18 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating bone deficit conditions
|
|
WO1999024432A1
(fr)
|
1997-11-12 |
1999-05-20 |
Mitsubishi Chemical Corporation |
Derives de purine et medicament les renfermant en tant qu'ingredient actif
|
|
US6191170B1
(en)
|
1998-01-13 |
2001-02-20 |
Tularik Inc. |
Benzenesulfonamides and benzamides as therapeutic agents
|
|
US7715989B2
(en)
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
|
JP2000072773A
(ja)
|
1998-08-28 |
2000-03-07 |
Zeria Pharmaceut Co Ltd |
プリン誘導体
|
|
CA2344249A1
(en)
|
1998-09-18 |
2000-03-30 |
Basf Aktiengesellschaft |
Pyrrolopyrimidines as protein kinase inhibitors
|
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
|
CA2344262A1
(en)
|
1998-09-18 |
2000-03-30 |
Basf Aktiengesellschaft |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
DK1140938T3
(da)
|
1999-01-11 |
2003-12-22 |
Univ Princeton |
Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
SE515856C2
(sv)
|
1999-05-19 |
2001-10-22 |
Ericsson Telefon Ab L M |
Bärare för elektronikkomponenter
|
|
JP2003501429A
(ja)
|
1999-06-03 |
2003-01-14 |
クノール・ゲー・エム・ベー・ハー |
ベンゾチアジノンおよびベンゾオキサジノン化合物
|
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
GB9919588D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
JP4831906B2
(ja)
|
1999-08-27 |
2011-12-07 |
ケモセントリックス， インコーポレイテッド |
Ｃｘｃｒ３機能を調節するための複素環式化合物および方法
|
|
AU780846B2
(en)
|
1999-09-16 |
2005-04-21 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
CA2385747A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Pyrazolopyrimidines as therapeutic agents
|
|
EP1222187B1
(en)
|
1999-10-06 |
2004-09-22 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
US6472153B1
(en)
|
1999-10-26 |
2002-10-29 |
Epoch Biosciences, Inc. |
Hybridization-triggered fluorescent detection of nucleic acids
|
|
JP2001151635A
(ja)
|
1999-11-19 |
2001-06-05 |
Lion Corp |
水中油型乳化皮膚外用剤
|
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
|
WO2001072751A1
(en)
|
2000-03-29 |
2001-10-04 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
|
MXPA02009543A
(es)
|
2000-03-29 |
2005-08-26 |
Abbott Gmbh & Co Kg |
Metodo para identificar inhibidores de tie-2.
|
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
ES2788383T3
(es)
|
2000-04-25 |
2020-10-21 |
Icos Corp |
Inhibidores de delta fosfatidilo-inositol 3-quinasa humana
|
|
JP2002037787A
(ja)
|
2000-05-16 |
2002-02-06 |
Kyowa Hakko Kogyo Co Ltd |
［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
|
|
US6777439B2
(en)
|
2000-05-30 |
2004-08-17 |
Advanced Research & Technology Institute, Inc. |
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
|
|
NZ522839A
(en)
|
2000-06-27 |
2004-11-26 |
Genelabs Tech Inc |
Novel compounds possessing antibacterial, antifungal or antitumor activity
|
|
US6534691B2
(en)
|
2000-07-18 |
2003-03-18 |
E. I. Du Pont De Nemours And Company |
Manufacturing process for α-olefins
|
|
AU1312502A
(en)
|
2000-10-11 |
2002-04-22 |
Pe Corp Ny |
Fluorescent nucleobase conjugates having anionic linkers
|
|
EP1578341A2
(en)
|
2000-10-11 |
2005-09-28 |
Tularik Inc. |
Modulation of ccr4 function
|
|
JP2002131859A
(ja)
|
2000-10-19 |
2002-05-09 |
Konica Corp |
撮影用赤外感光性ハロゲン化銀写真感光材料及び赤外感光性ハロゲン化銀乳剤
|
|
US6890747B2
(en)
|
2000-10-23 |
2005-05-10 |
Warner-Lambert Company |
Phosphoinositide 3-kinases
|
|
MXPA03005152A
(es)
|
2000-12-11 |
2004-10-14 |
Tularik Inc |
Antogonista de cxcr3.
|
|
US7157487B2
(en)
|
2000-12-28 |
2007-01-02 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
WO2002057425A2
(en)
|
2001-01-22 |
2002-07-25 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
DE60239097D1
(de)
|
2001-03-02 |
2011-03-17 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
US7250569B2
(en)
|
2001-04-26 |
2007-07-31 |
New York University School Of Medicine |
Method for dissolving nanostructural materials
|
|
DE60218458T2
(de)
|
2001-05-08 |
2007-11-15 |
Kudos Pharmaceuticals Ltd. |
Isochinolinon derivate als parp inhibitoren
|
|
US7144903B2
(en)
|
2001-05-23 |
2006-12-05 |
Amgen Inc. |
CCR4 antagonists
|
|
US6777425B2
(en)
|
2001-06-13 |
2004-08-17 |
Genesoft Pharmaceuticals, Inc. |
Isoquinoline compounds having antiinfective activity
|
|
US20030236198A1
(en)
|
2001-06-13 |
2003-12-25 |
Genesoft, Inc. |
Antipathogenic benzamide compounds
|
|
EP1470119A4
(en)
|
2001-06-13 |
2005-10-19 |
Genesoft Pharmaceuticals Inc |
BENZOTHIOPHENE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
|
|
AU2002315389A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
|
EP1414443B1
(en)
|
2001-08-01 |
2006-11-15 |
Merck & Co., Inc. |
BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES
|
|
WO2003020880A2
(en)
|
2001-08-03 |
2003-03-13 |
Abbott Laboratories |
Method of identifying inhibitors of lck
|
|
BR0211750A
(pt)
|
2001-08-10 |
2004-10-13 |
Shionogi & Co |
Agente antiviral
|
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するＲｈｏキナーゼ阻害剤
|
|
CA2458926A1
(en)
|
2001-09-13 |
2003-03-13 |
Genesoft Pharmaceuticals, Inc. |
Methods of treating infection by drug resistant bacteria
|
|
AUPR769501A0
(en)
|
2001-09-14 |
2001-10-11 |
Biomolecular Research Institute Limited |
Cytokine receptor 1
|
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
EP1438048A1
(en)
*
|
2001-10-18 |
2004-07-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
|
|
TWI330183B
(https=)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
US7319858B2
(en)
|
2001-11-16 |
2008-01-15 |
Cingular Wireless Ii, Llc |
System and method for querying message information
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
WO2003059884A1
(en)
|
2001-12-21 |
2003-07-24 |
X-Ceptor Therapeutics, Inc. |
Modulators of lxr
|
|
JP4085237B2
(ja)
|
2001-12-21 |
2008-05-14 |
日本電気株式会社 |
携帯電話の利用契約システムと通信方法
|
|
US7064218B2
(en)
|
2001-12-26 |
2006-06-20 |
Genelabs Technologies, Inc. |
Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
|
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
|
WO2003082341A1
(en)
|
2002-03-22 |
2003-10-09 |
Cellular Genomics, Inc. |
AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO[3,4-d] PYRIMIDINES AS KINASE MODULATORS
|
|
EP1503988B1
(de)
|
2002-03-26 |
2009-07-22 |
Biofrontera Discovery Gmbh |
Fredericamycin-derivate
|
|
US7166293B2
(en)
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
|
DE10217046A1
(de)
|
2002-04-17 |
2003-11-06 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
|
WO2003090751A1
(en)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
|
|
US6794562B2
(en)
|
2002-05-01 |
2004-09-21 |
Stine Seed Farm, Inc. |
Soybean cultivar 0332143
|
|
WO2004039774A2
(en)
|
2002-05-23 |
2004-05-13 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
WO2003106426A1
(en)
|
2002-06-14 |
2003-12-24 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
RU2340605C2
(ru)
|
2002-06-27 |
2008-12-10 |
Ново Нордиск А/С |
Арилкарбонильные производные в качестве терапевтических средств
|
|
US7265111B2
(en)
|
2002-06-27 |
2007-09-04 |
Sanofi-Aventis Deutschland Gmbh |
Adenosine analogues and their use as pharmaceutical agents
|
|
BR0312023A
(pt)
|
2002-06-27 |
2005-03-22 |
Novo Nordisk As |
Composto, composto ativador da glicose cinase, método para evitar a hipoglicemia, uso de um composto, e, composição farmacêutica
|
|
DE10230917A1
(de)
|
2002-07-09 |
2004-02-05 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
|
AU2003249244A1
(en)
|
2002-07-15 |
2004-02-02 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
|
WO2004014377A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
|
|
JP4646626B2
(ja)
|
2002-08-16 |
2011-03-09 |
アストラゼネカ アクチボラグ |
ホスホイノシチド３−キナーゼβの阻害
|
|
US20040048853A1
(en)
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
|
WO2004020610A2
(en)
|
2002-08-30 |
2004-03-11 |
President And Fellows Of Harvard College |
Methods and compositions for modulating xbp-1 activity
|
|
US7312341B2
(en)
*
|
2002-09-09 |
2007-12-25 |
Cgi Pharmaceuticals, Inc. |
6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
|
|
JP4487774B2
(ja)
|
2002-09-30 |
2010-06-23 |
萬有製薬株式会社 |
２−アミノベンズイミダゾール誘導体
|
|
JP2004161716A
(ja)
|
2002-11-15 |
2004-06-10 |
Takeda Chem Ind Ltd |
Ｊｎｋ阻害剤
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
ATE496893T1
(de)
|
2002-12-20 |
2011-02-15 |
X Ceptor Therapeutics Inc |
Isochinolinonderivate und deren verwendung als medikamente
|
|
US7247736B2
(en)
|
2002-12-23 |
2007-07-24 |
4Sc Ag |
Method of identifying inhibitors of DHODH
|
|
US7071355B2
(en)
|
2002-12-23 |
2006-07-04 |
4 Sc Ag |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
US7365094B2
(en)
|
2002-12-23 |
2008-04-29 |
4Sc Ag |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
CA2517942A1
(en)
|
2003-03-06 |
2004-09-16 |
Dsm Ip Assets B.V. |
Process for the preparation of an .alpha.-amino carbonyl compound
|
|
US7550590B2
(en)
|
2003-03-25 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
|
US7217794B2
(en)
|
2003-04-02 |
2007-05-15 |
Daiamed, Inc. |
Compounds and methods for treatment of thrombosis
|
|
WO2004100868A2
(en)
|
2003-04-23 |
2004-11-25 |
Abbott Laboratories |
Method of treating transplant rejection
|
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
|
US7429596B2
(en)
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
GB0317951D0
(en)
|
2003-07-31 |
2003-09-03 |
Trigen Ltd |
Compounds
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
EP1656378A4
(en)
|
2003-08-15 |
2011-05-11 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS INHIBITING TYROSINE KINASE RECEPTOR ACTIVITY
|
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
GB0322409D0
(en)
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
KR100872204B1
(ko)
*
|
2003-10-15 |
2008-12-09 |
오에스아이 파마슈티컬스, 인코포레이티드 |
이미다조피라진 티로신 키나제 억제제
|
|
AU2004289303A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
|
CA2546192C
(en)
|
2003-11-17 |
2010-04-06 |
Pfizer Products Inc. |
Pyrrolopyrimidine compounds useful in treatment of cancer
|
|
EP1692112A4
(en)
|
2003-12-08 |
2008-09-24 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS, AND METHODS
|
|
CA2548951A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US7569571B2
(en)
|
2003-12-23 |
2009-08-04 |
Novartis Ag |
Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators
|
|
US20050239809A1
(en)
|
2004-01-08 |
2005-10-27 |
Watts Stephanie W |
Methods for treating and preventing hypertension and hypertension-related disorders
|
|
JP2007520559A
(ja)
|
2004-02-03 |
2007-07-26 |
アボット・ラボラトリーズ |
治療薬としてのアミノベンゾオキサゾール類
|
|
UA83416C2
(en)
|
2004-02-13 |
2008-07-10 |
Баниу Фармасьютикал Ко., Лтд. |
Fused ring 4-oxopyrimidine derivative
|
|
US20050187418A1
(en)
|
2004-02-19 |
2005-08-25 |
Small Brooke L. |
Olefin oligomerization
|
|
WO2005080394A1
(en)
|
2004-02-24 |
2005-09-01 |
Bioaxone Therapeutique Inc. |
4-substituted piperidine derivatives
|
|
KR100843526B1
(ko)
|
2004-02-27 |
2008-07-03 |
에프. 호프만-라 로슈 아게 |
피라졸의 접합 유도체
|
|
TWI378934B
(en)
*
|
2004-04-02 |
2012-12-11 |
Osi Pharm Inc |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
|
BRPI0510305A
(pt)
|
2004-04-30 |
2007-10-02 |
Takeda Pharmaceutical |
composto ou um sal do mesmo, pródroga ou um sal da mesma, agente farmacêutico, método de produção do composto ou um sal do mesmo, inibidor de metaloproteinase de matriz ou um sal do mesmo ou uma pródroga do mesmo, método de inibir uma metaloproteinase de matriz, e, uso de um composto ou de um sal do mesmo ou de uma pródroga do mesmo
|
|
DE102004022897A1
(de)
|
2004-05-10 |
2005-12-08 |
Bayer Cropscience Ag |
Azinyl-imidazoazine
|
|
CA2730540A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
SI2612862T1
(sl)
|
2004-05-13 |
2017-04-26 |
Icos Corporation |
Kinazolini kot inhibitorji humane fosfatidilinozitol 3-kinaze delta
|
|
JP2008500338A
(ja)
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び／又は予防する方法
|
|
MXPA06013805A
(es)
|
2004-05-27 |
2007-02-02 |
Pfizer Prod Inc |
Derivados de pirrolopirimidina de utilidad en el tratamiento contra el cancer.
|
|
CA2569406A1
(en)
|
2004-06-04 |
2005-12-22 |
Icos Corporation |
Methods for treating mast cell disorders
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
|
GB0423554D0
(en)
*
|
2004-10-22 |
2004-11-24 |
Cancer Rec Tech Ltd |
Therapeutic compounds
|
|
US8212012B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
|
WO2006050501A2
(en)
|
2004-11-03 |
2006-05-11 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
|
US8212011B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues
|
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
US8143257B2
(en)
|
2004-11-23 |
2012-03-27 |
Ptc Therapeutics, Inc. |
Substituted phenols as active agents inhibiting VEGF production
|
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
WO2006089106A2
(en)
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
US7579348B2
(en)
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
|
US20090124654A1
(en)
|
2005-03-01 |
2009-05-14 |
Mjalli Adnan M M |
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
|
|
RU2007138264A
(ru)
|
2005-03-17 |
2009-09-10 |
Новартис АГ (CH) |
N-[3-(1-АМИНО-5,6,7,8-ТЕТРАГИДРО-2,4,4b-ТРИАЗАФЛУОРЕН-9-ИЛ)ФЕНИЛ]БЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИН/ТРЕОНИНКИНАЗ, ПРЕЖДЕ ВСЕГО КИНАЗ В-RAF
|
|
RU2007140733A
(ru)
|
2005-04-06 |
2009-05-20 |
Айрм Ллк (Bm) |
Диариламинсодержащие соединения и композиции, и их применение в качестве модуляторов ядерных рецепторов стероидного гормона
|
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
|
JP5033119B2
(ja)
|
2005-04-25 |
2012-09-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
キナーゼ阻害剤としての新規アザ複素環化合物
|
|
WO2006114064A2
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
|
BRPI0612112A8
(pt)
|
2005-06-22 |
2017-12-26 |
Chemocentryx Inc |
composto, composição farmacêutica, e, método de tratar doenças ou condições mediadas por ccr1.
|
|
CA2612585A1
(en)
|
2005-06-27 |
2007-01-04 |
Amgen Inc. |
Anti-inflammatory aryl nitrile compounds
|
|
JP2009500437A
(ja)
|
2005-07-11 |
2009-01-08 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
|
JP2009505948A
(ja)
|
2005-07-11 |
2009-02-12 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
|
GB0516723D0
(en)
|
2005-08-15 |
2005-09-21 |
Novartis Ag |
Organic compounds
|
|
WO2007025090A2
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
|
|
RU2008110941A
(ru)
|
2005-08-25 |
2009-09-27 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
ИНГИБИТОРЫ КИНАЗЫ p38 МАР И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
US20080318942A1
(en)
|
2005-09-01 |
2008-12-25 |
Bioagency Ag |
Fredericamycin Derivatives
|
|
CA2624220A1
(en)
|
2005-09-29 |
2007-04-12 |
Wyeth |
1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
|
|
EP2385053B1
(en)
|
2005-11-17 |
2013-10-02 |
OSI Pharmaceuticals, Inc. |
Intermediates for the preparation of fused bicyclic mTOR inhibitors
|
|
AU2006316321A1
(en)
|
2005-11-22 |
2007-05-31 |
Merck & Co., Inc. |
Indole orexin receptor antagonists
|
|
AR057960A1
(es)
*
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
|
WO2007066189A2
(en)
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
|
JP2009520028A
(ja)
|
2005-12-19 |
2009-05-21 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
Ｉｇｆｒ抑制剤および抗癌剤の併用
|
|
TW200801008A
(en)
|
2005-12-29 |
2008-01-01 |
Abbott Lab |
Protein kinase inhibitors
|
|
WO2007089669A2
(en)
|
2006-01-26 |
2007-08-09 |
Wyeth |
Processes for the preparation of compounds which modulate cell proliferation
|
|
US7659283B2
(en)
|
2006-02-14 |
2010-02-09 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases
|
|
AU2007220039A1
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitors of the unfolded protein response and methods for their use
|
|
BRPI0708615A2
(pt)
|
2006-03-07 |
2011-06-07 |
Array Biopharma Inc |
compostos de pirazol heterobicìclicos e métodos de uso
|
|
EP1996193A2
(en)
*
|
2006-03-13 |
2008-12-03 |
OSI Pharmaceuticals, Inc. |
Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
|
|
EP2004683B1
(en)
|
2006-03-24 |
2016-05-11 |
Biogen Hemophilia Inc. |
Pc5 as a factor ix propeptide processing enzyme
|
|
CA2647543A1
(en)
|
2006-03-29 |
2007-11-08 |
Foldrx Pharmaceuticals, Inc. |
Inhibition of alpha-synuclein toxicity
|
|
WO2007114926A2
(en)
|
2006-04-04 |
2007-10-11 |
The Regents Of The University Of California |
Kinase antagonists
|
|
WO2007121453A2
(en)
|
2006-04-17 |
2007-10-25 |
The Regents Of The University Of California |
2-hydroxy-1-oxo 1,2 dihydro isoquinoline chelating agents
|
|
EP2322525B1
(en)
|
2006-04-21 |
2013-09-18 |
Novartis AG |
Purine derivatives for use as adenosin A2A receptor agonists
|
|
GB0607948D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
|
GB0607950D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
|
WO2007125315A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
EP2037931A2
(en)
|
2006-04-25 |
2009-03-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations of pk inhibitors and other active agents
|
|
DE102006020327A1
(de)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
|
|
WO2007135398A1
(en)
|
2006-05-22 |
2007-11-29 |
Astrazeneca Ab |
Indole derivatives
|
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
|
GB0610317D0
(en)
|
2006-05-24 |
2006-07-05 |
Medical Res Council |
Antiparasitic compounds and compositions
|
|
ES2344760T3
(es)
|
2006-07-20 |
2010-09-06 |
Amgen Inc. |
Compuestos de piridona sustituidos y metodo de uso.
|
|
WO2008023357A1
(en)
|
2006-08-22 |
2008-02-28 |
Technion Research And Development Foundation Ltd. |
Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
|
|
JP2010501593A
(ja)
|
2006-08-24 |
2010-01-21 |
セレネックス， インコーポレイテッド |
イソキノリン、キナゾリンおよびフタラジン誘導体
|
|
US7956064B2
(en)
|
2006-09-01 |
2011-06-07 |
Cylene Pharmaceuticals, Inc. |
Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
|
|
WO2008025755A1
(de)
|
2006-09-01 |
2008-03-06 |
Basf Se |
Verwendung von n-haltigen heterozyklen in dermokosmetika
|
|
EP1903044A1
(en)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
|
WO2008037477A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as p13k lipid kinase inhibitors
|
|
EP2077267A4
(en)
|
2006-10-18 |
2010-04-07 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
KR20090087027A
(ko)
|
2006-11-13 |
2009-08-14 |
일라이 릴리 앤드 캄파니 |
염증 질환 및 암의 치료를 위한 티에노피리미디논
|
|
WO2008063625A2
(en)
|
2006-11-20 |
2008-05-29 |
Adolor Corporation |
Pyridine compounds and methods of their use
|
|
CN101611007A
(zh)
|
2006-12-20 |
2009-12-23 |
先灵公司 |
新颖的jnk抑制剂
|
|
EP2114925B8
(en)
|
2006-12-22 |
2013-04-10 |
Industrial Research Limited |
Azetidine analogues of nucleosidase and phosphorylase inhibitors
|
|
CN101622001A
(zh)
|
2007-01-26 |
2010-01-06 |
Irm责任有限公司 |
作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物
|
|
US8586619B2
(en)
|
2007-03-12 |
2013-11-19 |
Vm Therapeutics Llc |
Agents of calcium ion channel modulators
|
|
RS53151B
(sr)
|
2007-03-23 |
2014-06-30 |
Amgen Inc. |
3-supstituisani derivati hinolina ili hinoksalina i njihova upotreba kao inhibitora fosfatidilinozitol 3-kinaze (pi3k)
|
|
EA017389B1
(ru)
|
2007-03-23 |
2012-12-28 |
Амген Инк. |
Гетероциклические соединения и их применение
|
|
WO2008118454A2
(en)
|
2007-03-23 |
2008-10-02 |
Amgen Inc. |
Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
|
|
US7867983B2
(en)
|
2007-03-29 |
2011-01-11 |
The University Of Connecticut |
Methods to protect skeletal muscle against injury
|
|
WO2008125207A1
(en)
|
2007-04-13 |
2008-10-23 |
Sanofi-Aventis |
A transition metal catalyzed synthesis of n-aminoindoles
|
|
CN101636397B
(zh)
|
2007-04-13 |
2012-06-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
脲类化合物、其制备方法及其医药用途
|
|
JP2010163361A
(ja)
|
2007-04-27 |
2010-07-29 |
Dainippon Sumitomo Pharma Co Ltd |
キノリン誘導体
|
|
CN101730700A
(zh)
*
|
2007-05-09 |
2010-06-09 |
雅培制药有限公司 |
用作蛋白激酶抑制剂的稠合杂环化合物
|
|
WO2008141140A1
(en)
*
|
2007-05-09 |
2008-11-20 |
Abbott Laboratories |
Condensed heterocyclic compounds as inhibitors of protein kinases
|
|
US7960353B2
(en)
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
|
WO2008147852A1
(en)
|
2007-05-22 |
2008-12-04 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
|
EP2520561B1
(en)
|
2007-06-08 |
2016-02-10 |
MannKind Corporation |
IRE-1A Inhibitors
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
BRPI0813273A2
(pt)
|
2007-06-26 |
2014-12-30 |
Sanofi Aventis |
Síntese catalisada por metal regiosseletivo de benzimidazóis e azabenzimidazóis anelados
|
|
EP2170274A1
(en)
|
2007-07-02 |
2010-04-07 |
Technion Research and Development Foundation, Ltd. |
Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage
|
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
|
CA2696113A1
(en)
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
WO2009023718A2
(en)
|
2007-08-13 |
2009-02-19 |
Metabasis Therapeutics, Inc. |
Novel activators of glucokinase
|
|
JP5227965B2
(ja)
|
2007-10-03 |
2013-07-03 |
独立行政法人理化学研究所 |
ニトロトリアゾール誘導体、およびそれを用いる化合物の製造方法
|
|
WO2009050506A2
(en)
|
2007-10-15 |
2009-04-23 |
Astrazeneca Ab |
Combination 059
|
|
JP5256693B2
(ja)
|
2007-10-31 |
2013-08-07 |
信越化学工業株式会社 |
酸化チタン系光触媒薄膜の製造法
|
|
US20100331297A1
(en)
|
2007-11-07 |
2010-12-30 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
|
CA2716334A1
(en)
|
2007-11-13 |
2009-05-22 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
US20090163481A1
(en)
|
2007-12-13 |
2009-06-25 |
Murphy Brian J |
Ppar-delta ligands and methods of their use
|
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
|
EP3613743B1
(en)
|
2008-01-04 |
2022-03-16 |
Intellikine, LLC |
Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
JP2011509305A
(ja)
|
2008-01-09 |
2011-03-24 |
ピージーエックスヘルス、リミテッド、ライアビリティー、カンパニー |
Ａ２ａｒアゴニストによる神経障害性疼痛の髄腔内治療
|
|
JP2011510018A
(ja)
|
2008-01-18 |
2011-03-31 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
癌治療のためのイミダゾピラジノール誘導体
|
|
CN101983062A
(zh)
|
2008-02-07 |
2011-03-02 |
吉利德帕洛阿尔托股份有限公司 |
提高abca-1的化合物及其用途
|
|
EP2244709A4
(en)
|
2008-02-07 |
2012-02-29 |
Synta Pharmaceuticals Corp |
TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS
|
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
ES2413806T3
(es)
|
2008-03-20 |
2013-07-17 |
Amgen Inc. |
Moduladores de la aurora cinasa y método de uso
|
|
EP2283020B8
(en)
*
|
2008-05-19 |
2012-12-12 |
OSI Pharmaceuticals, LLC |
Substituted imidazopyr-and imidazotri-azines
|
|
US20090312406A1
(en)
|
2008-06-12 |
2009-12-17 |
Hsing-Pang Hsieh |
Coumarin compounds and their use for treating viral infection
|
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン， エルエルシー |
キナーゼインヒビターおよび使用方法
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
JP2011528368A
(ja)
|
2008-07-16 |
2011-11-17 |
シェーリング コーポレイション |
二環式ヘテロ環誘導体およびｇｐｃｒモジュレーターとしてのその使用
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
US9284297B2
(en)
|
2008-08-11 |
2016-03-15 |
President And Fellows Of Harvard College |
Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
|
|
WO2010039534A2
(en)
|
2008-09-23 |
2010-04-08 |
Georgetown University |
Viral and fungal inhibitors
|
|
US8703778B2
(en)
|
2008-09-26 |
2014-04-22 |
Intellikine Llc |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
WO2010059593A1
(en)
|
2008-11-18 |
2010-05-27 |
Intellikine, Inc. |
Methods and compositions for treatment of ophthalmic conditions
|
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
CN101602768B
(zh)
|
2009-07-17 |
2012-05-30 |
河南省农科院农副产品加工研究所 |
一种芝麻素和芝麻林素的提纯方法
|
|
HRP20160967T1
(hr)
|
2009-10-06 |
2016-10-07 |
Millennium Pharmaceuticals, Inc. |
Heterociklički spojevi korisni kao pdk1 inhibitori
|
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
|
WO2011094628A1
(en)
*
|
2010-01-28 |
2011-08-04 |
University Of Washington |
Compositions and methods for treating toxoplasmosis. cryptosporidiosis and other apicomplexan protozoan related diseases
|
|
EP2555768B1
(en)
|
2010-04-05 |
2018-08-29 |
Fosun Orinove Pharmatech, Inc. |
Ire-1 inhibitors
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
WO2012064774A1
(en)
|
2010-11-10 |
2012-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
An ire1alpha endonuclease specific inhibitor with cytotoxic activity
|
|
US9295673B2
(en)
|
2011-02-23 |
2016-03-29 |
Intellikine Llc |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
|
|
BR112014001255B1
(pt)
*
|
2011-07-19 |
2019-07-02 |
Merck Sharp & Dohme B.V. |
Composto, uso de um composto, combinação, composição farmacêutica, e, sal farmaceuticamente aceitável de um composto
|
|
EP2548877A1
(en)
*
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
MX2015003874A
(es)
|
2012-09-26 |
2015-12-16 |
Univ California |
Modulacion de ire1.
|
|
WO2016004254A1
(en)
|
2014-07-01 |
2016-01-07 |
The Regents Of The University Of California |
Combined modulation of ire1
|